Roche Holding AG and Ferring Pharmaceuticals collaborate to develop personalised infertility treatment

Tuesday, 24 Jun 2014 04:00am EDT 

Roche Holding AG and Ferring Pharmaceuticals:Announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development.Roche will work with Ferring and its global phase III programme to qualify, validate, document and seek regulatory approval for a companion diagnostic test to be used in combination with Ferring's human rFSH. 

Company Quote

25 Nov 2014